FAILED
首站-论文投稿智能助手
典型文献
Assessment of respiratory support decision and the outcome of invasive mechanical ventilation in severe COVID-19 with ARDS ☆
文献摘要:
Background::The coronavirus disease 2019 (COVID-19) is an ongoing pandemic. Invasive mechanical ventilation (IMV) is essential for the management of COVID-19 with acute respiratory distress syndrome (ARDS). We aimed to assess the impact of compliance with a respiratory decision support system on the outcomes of patients with COVID-19-associated ARDS who required IMV.Methods::In this retrospective, single-center, case series study, patients with COVID-19-associated ARDS who required IMV at Zhongnan Hospital of Wuhan University, China, from January 8th, 2020, to March 24th, 2020, with the final follow-up date of April 20th, 2020, were included. Demographic, clinical, laboratory, imaging, and management information were collected and analyzed. Compliance with the respiratory support decision system was documented, and its relationship with 28-day mortality was evaluated.Results::The study included 46 COVID-19-associated ARDS patients who required IMV. The median age of the 46 patients was 68.5 years, and 31 were men. The partial pressure of arterial oxygen (PaO 2)/fraction of inspired oxygen (FiO 2) ratio at intensive care unit (ICU) admission was 104 mmHg. The median total length of IMV was 12.0 (interquartile range [IQR]: 6.0-27.3) days, and the median respiratory support decision score was 11.0 (IQR: 7.8-16.0). To 28 days after ICU admission, 18 (39.1%) patients died. Survivors had a significantly higher respiratory support decision score than non-survivors (15.0 [10.3-17.0] vs. 8.5 (6.0-10.3), P = 0.001). Using receiver operating characteristic (ROC) curve to assess the discrimination of respiratory support decision score to 28-day mortality, the area under the curve (AUC) was 0.796 (95% confidence interval [CI]: 0.657-0.934, P = 0.001) and the cut-off was 11.5 (sensitivity = 0.679, specificity = 0.889). Patients with a higher score ( >11.5) were more likely to survive at 28 days after ICU admission (log-rank test, P < 0.001). Conclusions::For severe COVID-19-associated ARDS with IMV, following the respiratory support decision and assessing completion would improve the progress of ventilation. With a decision score of >11.5, the mortality at 28 days after ICU admission showed an obvious decrease.
文献关键词:
COVID-19;Acute respiratory distress syndrome (ARDS);Respiratory support decision;Invasive mechanical ventilation;Severe acute respiratory coronavirus 2;(SARS-CoV-2)
作者姓名:
Cai Shuhan;Zhu Fangfang;Hu Hongtao;Xiang Hui;Wang Dawei;Wang Jing;Li Lu;Yang Xiao;Qin Aihua;Rao Xin;Luo Yun;Li Jianguo;Kashani Kianoush B.;Hu Bo;Peng Zhiyong
作者机构:
Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China;Clinical Research Center of Hubei Critical Care Medicine, Wuhan, Hubei 430071, China;Division of Nephrology and Hypertension, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA;Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA
引用格式:
[1]Cai Shuhan;Zhu Fangfang;Hu Hongtao;Xiang Hui;Wang Dawei;Wang Jing;Li Lu;Yang Xiao;Qin Aihua;Rao Xin;Luo Yun;Li Jianguo;Kashani Kianoush B.;Hu Bo;Peng Zhiyong-.Assessment of respiratory support decision and the outcome of invasive mechanical ventilation in severe COVID-19 with ARDS ☆)[J].重症医学(英文),2022(02):92-102
A类:
ARDS ,Zhongnan
B类:
Assessment,respiratory,support,decision,invasive,mechanical,ventilation,severe,Background,coronavirus,disease,ongoing,pandemic,Invasive,IMV,essential,management,acute,distress,syndrome,We,aimed,impact,compliance,system,outcomes,patients,associated,who,required,Methods,this,retrospective,single,center,case,series,study,Hospital,Wuhan,University,China,from,January,8th,March,24th,final,date,April,20th,were,included,Demographic,clinical,laboratory,imaging,information,collected,analyzed,Compliance,was,documented,its,relationship,mortality,evaluated,Results,median,years,partial,pressure,arterial,oxygen,PaO ,fraction,inspired,FiO ,ratio,intensive,care,unit,ICU,admission,mmHg,total,length,interquartile,range,IQR,days,score,To,after,died,Survivors,had,significantly,higher,than,survivors,Using,receiver,operating,characteristic,curve,discrimination,area,under,confidence,interval,off,sensitivity,specificity,Patients,more,likely,survive,log,rank,test,Conclusions,For,following,assessing,completion,would,improve,progress,With,showed,obvious,decrease,Acute,Respiratory,Severe,SARS,CoV
AB值:
0.487058
相似文献
Development and evaluation of a predictive nomogram for survival in heat stroke patients: a retrospective cohort study
Fei Shao;Xian Shi;Shu-hua Huo;Qing-yu Liu;Ji-xue Shi;Jian Kang;Ping Gong;Sheng-tao Yan;Guo-xingWang;Li-jie Qin;Fei Wang;Ke Feng;Feng-ying Chen;Yong-jie Yin;Tao Ma;Yan Li;Yang Wu;Hao Cui;Chang-xiao Yu;Song Yang;Wei Gan;Sai Wang;Liu-ye-zi Du;Ming-chen Zhao;Zi-ren Tang;Shen Zhao-Department of Emergency Medicine,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China;Department of Emergency Medicine,Hebei Yanda Hospital,Langfang 065201,China;Department of Emergency Medicine,Beijing Huairou Hospital,Beijing 101400,China;Department of Emergency Medicine,the Second Hospital of Hebei Medical University,Shijiazhuang 050000,China;Department of Emergency Medicine,the Second Affiliated Hospital of Shandong First Medical University,Tai'an 271000,China;Department of Emergency Medicine,the First Affiliated Hospital of Dalian Medical University,Dalian 116011,China;Department of Emergency Medicine,China-Japan Friendship Hospital,Beijing 100029,China;Department of Emergency Medicine,Beijing Friendship Hospital,Beijing 100050,China;Department of Emergency Medicine,Henan Provincial People's Hospital,Zhengzhou 450003,China;Department of Emergency Medicine,Beijing Tsinghua Changung Hospital,Beijing 102218,China;Department of Emergency Medicine,General Hospital of Ningxia Medical University,Yinchuan 750004,China;Department of Emergency Medicine,the Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China;Department of Emergency Medicine,the Second Hospital of Jilin University,Changchun 130021,China;Department of Emergency Medicine,the First Hospital of China Medical University,Shenyang 110001,China;Department of Emergency Medicine,the Second Hospital of Shanxi Medical University,Taiyuan 030001,China;Department of Big Data Research,Goodwill Hessian Health Technology Co.,Ltd.,Beijing 100085,China;School of Public Health,Peking University,Beijing 100083,China;Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation,Beijing 100020,China;Department of Critical Care Medicine,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China
Homeopathy for COVID-19 in primary care:A randomized,double-blind,placebo-controlled trial(COVID-Simile study)
Ubiratan Cardinalli Adler;Maristela Schiabel Adler;Ana Elisa Madureira Padula;Livia Mitchiguian Hotta;Amarilys de Toledo Cesar;José Nelson Martins Diniz;Helen de Freitas Santos;Edson Zangiacomi Martinez-Department of Medicine,Federal University of S?o Carlos,S?o Carlos 13565-905,Brazil;Homeopathy Solidarity Outpatient Extension Program,Mackenzie Presbyterian University,S?o Paulo 01302-907,Brazil;Municipal Center for Integrative and Complementary Practices in Health,Guarulhos 07023-051,Brazil;HN-Cristiano Institute,S?o Paulo 02013-001,Brazil;School Health Unit,Federal University of S?o Carlos,Sao Carlos 13565-905,Brazil;Federal Institute of Education,Science and Technology of S?o Paulo,Birigui 16201-407,Brazil;Department of Social Medicine,Ribeir?o Preto Medical School,University of Sao Paulo,Ribeirao Preto 14049-900,Brazil
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。